Page 2 - Peter Newcomer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. That's an urgent but daunting challenge in Michigan, where hospitals are struggling to keep up with a surge in new cases. Monoclonal antibodies can hold the coronavirus in check by mimicking the body's natural immune defenses. The drugs, produced by Regeneron and Eli Lilly, can keep people with mild to moderate COVID-19 out of the hospital and have emergency authorization for people over 65, as well as others with certain underlying health conditions. On Wednes...

Michigan Office of the Governor/AP hide caption toggle caption Michigan Office of the Governor/AP In an update on COVID-19 Wednesday, Michigan Gov. Gretchen Whitmer discussed the state's efforts to expand the use of monoclonal antibody therapy to help those diagnosed with COVID-19 avoid hospitalization. Michigan Office of the Governor/AP Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. That's an urgent but daunting challenge in Michigan, where hospitals are struggling t...

Copy shortlink: More than a month after shipments of a promising new COVID-19 treatment started arriving in Minnesota, most of the doses haven't been used even though doctors initially feared demand would far outstrip supply. State health officials say some medical centers have reported a surprising lack of patient interest in the outpatient antibody therapy, which might help people avoid hospitalization, but requires an hourlong infusion. Health systems also have struggled to create a process for providing the treatment, since resources have been stretched thin as the...

Low Demand For Antibody Drugs Against COVID-19 Update RequiredTo play audio, update browser or Flash plugin. President Trump boards Marine One for a trip from the White House to Walter Reed National Military Medical Center for COVID-19 treatment in early October. Trump received Regeneron's antibody cocktail during his illness. Alex Brandon / AP Federal officials are disappointed to find that the monoclonal antibody drugs they've shipped across the country aren't being used rapidly. These drugs are designed to prevent people recently diagnosed with COVID-19 from ending up in the ...

  / President Trump boards Marine One for a trip from the White House to Walter Reed National Military Medical Center for COVID-19 treatment in early October. Trump received Regeneron's antibody cocktail during his illness. // AP, Alex Brandon Federal officials are disappointed to find that the monoclonal antibody drugs they've shipped across the country aren't being used rapidly. These drugs are designed to prevent people recently diagnosed with COVID-19 from ending up in the hospital. But hospitals are finding it cumbersome to use these medicines, which must be given by IV infusion. ...